신질환 환아에서 초음파 골량측정법을 이용한 골상태 평가
Assesment of Bone Strength Using a New Quantitative Ultrasound Device in Chidren with Renal Diseases
1
조회
0
다운로드
0
인용
0
참고문헌
초록
목 적:소아 신질환 환자들의 골상태 평가 및 골다공증의 유병률을 산출하고 스테로이드 치료기간 및 용량과의 연관성을 알아본 후 예방과 치료를 위한 진료에 지침을 마련하고자 시행하였다. 방 법:1994년 이후 아주대병원 소아과에서 신장질환을 진단 받은 환자들을 대상으로 초음파 골량측정법으로 골밀도를 측정한 후 한국 소아 표준골밀도치를 참조하여 골상태를 평가하였고 환자의 임상소견 및 생화학적 지표들의 평균값간에 차이가 있는 지를 알아보았다. 결 과:골밀도를 측정 받은 환자는 총44명이었다. 진단시 나이는 6.7±4.2세였고, 골밀도 측정시 역연령은 9.3±4.2세, 골연령은 8.2±4.6세로 골연령이 저하되어 있었다. 질환별로는 특발성 신증후군 24명(54.5%), Henoch Shönlein 신염 7명(15.9%), IgA 신병증 6명(13.6%), 역류성 신병증 2명(4.5%), 기타 5명(11.4%)이었다. 환아 13명(29%)의 골밀도가 감소되어 있었고 이중 5명(11%)은 골다공증 범주에 속하였다. 질환별로는 특발성 신증후군 1명(4%), Henoch Shönlein 신염 2명(29%), 역류성 신병증 1명(50%), 기타 1명(23%)이었다. 정상, 골감소증, 골다공증 세 군으로 나누었을 때 골밀도 측정시점까지 스테로이드 투여기간은 각각 26.5±27.3개월, 32.1±39.6개월, 8.9±12.9개월이었고, 투여한 축적 용량은 221.7±248.6 mg/kg, 177.1±302.9 mg/kg, 49.9±45.5 mg/kg이었으며 세 군간에 유의한 차이는 없었다. 스테로이드의 투여기간을 장기간(6개월 이상)과 단기간(6개월 미만)으로 나누어 비교했을 때 골밀도 측정값 및 골관련 생화학적 수치들은 차이가 없었다. 결 론:초음파 골량측정법이 보편화되지 않았지만 정상 참고치와 비교가 가능하였으며 측정결과 골감소증은 29%, 골다공증은 11%로 상당수에서 골상태가 비정상임을 알 수 있었다. 본 연구에서는 스테로이드 사용기간 및 축적용량이 골상태의 변화에 특별한 영향을 미치지 않는 것으로 나타났다. 동일 환자들의 골상태의 변화관찰과 신질환 관련 골감소의 요인을 밝혀내기 위한 추가적인 연구가 필요할 것으로 사료된다.
Abstract
Purpose:Metabolic bone diseases have been major problems in children with renal diseases and steroid treatment is the main precipitating factor reducing bone mineral density(BMD). This study was performed to assess the prevalence of osteoporosis and to evaluate the clinical factors associated with decreased BMD in children with renal diseases. Methods:Forty-four children with renal diseases who were diagnosed at the pediatric nephrology division of Ajou University hospital since Oct. 1994 were included. Using a new quantitative ultrasound device, BMD and the prevalence of osteoporosis were evaluated. The clinical and serological data were analyzed in association with decreased BMD. Results:A total of 44 patients were evaluated. The age at initial diagnosis was 6.7±4.2 years. At the time of evaluation, the chronological and bone age was 9.3±4.2 years and 8.2±4.6 years, respectively. The renal diseases included nephrotic syndrome 24(54.5%), Henoch Schonlein purpura nephritis 7(15.9%), IgA nephropathy 6(13.9%), reflux nephropathy(RN) 2 (4.5%), and other renal disease 5(%). The prevalence of osteoporosis was 11%. There was no difference in the clinical factors between the long-term and the short-term treated steroid groups. Conclusion:The prevalence of osteoporosis was 12% in 44 children with renal diseases. No significant factor was found in association with decreased BMD and there was no relationship between osteoporosis and steroid usage duration or cumulative dose. A new quantitative ultrasound, which is relatively easy to perform, especially in children, is expected to be in common use and will enable clinicians to evaluate metabolic bone disorders with ease.
참고문헌 (29)
- Mushtag T, "The impact of corticosteroids on growth and bone health", 87, pp.93~6
- Madan G, "Are children with idiopathic nephritic syndrome at risk for metabolic bone disease? Am J Kid Dis 2003;41", 41, pp.1163~9 (2003)
- Van Rijn RR, "Bone Densitometry in children Smeinars in Musculoskeletal Radiology", 6, pp.233~9 (2002)
- Van Rijn RR,, "Bone densitometry in children:a critical appraisal.", 13, pp.700~10 (2003)
- Abrass CK, "Clinical spectrum and complications of the nephrotic syndrome", 45, pp.143~53 (1997)
- Frost HM, "The effect of cortisone on lamellar osteoblastic acitivity", pp.97~101, Villaneuva AR
- Rajiv K, "Glucocorticoid-induced osteoporosis. Curr Opin Neph Hypertension", 10, pp.589~95 (2001)
- Suzuki Y, "Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy", pp.151~6
- Hahn TJ, "Effects of short-term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man", pp.111~5
- Hollister JR, "Steroid induced fractures and bone loss in patients with asthma", adi(ff ad), pp.265~8
- Hahn TJ, "Osteopenia in patients with rheumatic diseases principle of diagnosis and therapy", pp.165~88
- Adachi JD, "Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis", 23, pp.995~1000 (1996)
- Morin D, "Measurement of bone mineral content by dual photon absorptiometry in children with nephrotic syndrome treated with corticosteroid therapy over a long period"
- Ceasre P,, "Bone mineral content in nephrotic children on long term, alternate-day prednisone therapy. Clin Pediatr", pp.234~6 (1995)
- Van Der Slius IM, "Referance data for bone density and body composition measured with drual energy x ray absorptionmetry in white children and young adults", 87, pp.341~7 (2002)
- Warner JT, "Measured and predicted bone mineral content in healthy boys and girls aged 6-18 years adjustment for body size and puberty", 87, pp.244~9 (1998)
- Boloton HH, "An analysis and quantitative exposition of patient-specific systematic inaccurancies inherent in planar DXA- derived in-vivo BMD measurements", 25, pp.139~51 (1998)
- Bolotin HH,, "Inaccurancies inherent in patient-specific dual energy x ray absorptionmetry bone mineral density measurements", 16, pp.417~26 (2001)
- Harry KG, "Noninvasive assessment of bone mineral and structure: state of the art.", 11, pp.707~30 (1996)
- Lequin MH,, "Normal values for tibial quantitiative ultrasonometry in Caucasian children and adolescents", 67, pp.101~5 (2000)
- Van Rijn RR, "Tibial quantitative ultrasound versus whole-body and lumbar spine DXA in a Dutch pediatric and adolescent population", 359, pp.548~52 (2000)
- Picado C, "Vertebral fractures in steroid dependent asthma and involution osteoporosis", pp.803~6
- Hahn TJ, "Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass", pp.274~82
- Freundlich M, "Calcium and vitamin D metabolism metabolism in children with nephritic syndrome", pp.383~7
- Celotti F,, "Dietary calcium and mineral", vitamin supplementation:a controversial problem, 1999, pp.27, 1~14
- Jehle MJ, "Use of corticosteroids in nephrology. Risk and prevention of osteoporosis induction. Nephrol Dial Transplant", 15, pp.565~5 (2000)
- "The course of biochemical parametes of bone turnover during treatment with corticosteroids", pp.392~6
- Harold NR, "Biochemical markers of bone turnover Curr Opin in Endo Diabetes", 10, pp.387~93 (2003)
- Kanis JA, "The diagnosis of osteoporosis", pp.1137~41